Quality of Life Measures for Acne Patients

Dermatologic Clinics

Volumn 30, Issue 2, 2012, Pages 293-300

  Barnes, Lauren E ^a   Levender, Michelle M ^a,b   Fleischer, Alan B ^a   Feldman, Steven R ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Anxiety; Depression; Psychometric; Psychosocial burden

Indexed keywords

ISOTRETINOIN;

ACNE; ACNE DISABILITY INDEX; ACNE QUALITY OF LIFE; ACNE QUALITY OF LIFE INDEX; AGE DISTRIBUTION; ANXIETY; ASSESSMENT OF THE PSYCHOLOGICAL AND SOCIAL EFFECTS OF ACNE; AVOIDANCE BEHAVIOR; BECK DEPRESSION INVENTORY; CARDIFF ACNE DISABILITY INDEX; CLINICAL PRACTICE; COMORBIDITY; COST OF ILLNESS; DEPRESSION; DERMATOLOGY LIFE QUALITY INDEX; EMOTION; HUMAN; ONSET AGE; PRIORITY JOURNAL; PSYCHOLOGICAL WELL BEING; QUALITY OF LIFE; QUESTIONNAIRE; QUESTIONNAIRE OF CHRONIC SKIN DISORDER; REVIEW; RISK FACTOR; SELF ESTEEM; SKINDEX; SOCIAL PSYCHOLOGY; SOCIOECONOMICS; SYSTEMATIC REVIEW; UNITED KINGDOM SICKNESS IMPACT PROFILE;

ACNE VULGARIS; HEALTH STATUS; HUMANS; QUALITY OF LIFE; QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 84856290774     PISSN: 07338635     EISSN: 15580520     Source Type: Journal    
DOI: 10.1016/j.det.2011.11.001     Document Type: Review

References (53)

1. Krejci-Manwaring J., Kerchner K., Feldman S.R., et al. Social sensitivity and acne: the role of personality in negative social consequences and quality of life. Int J Psychiatry Med 2006, 36(1):121-130.
2. Yentzer B.A., Hick J., Reese E.L., et al. Acne vulgaris in the United States: a descriptive epidemiology. Cutis 2010, 86(2):94-99.
3. Friedlander S.F., Eichenfield L.F., Fowler J.F., et al. Acne epidemiology and pathophysiology. Semin Cutan Med Surg 2010, 29(2 Suppl 1):2-4.
4. Jowett S., Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med 1985, 20(4):425-429.
5. Koo J. The psychosocial impact of acne: patients' perceptions. JAm Acad Dermatol 1995, 32(5 Pt 3):S26-S30.
6. Koo J.Y., Smith L.L. Psychologic aspects of acne. Pediatr Dermatol 1991, 8(3):185-188.
7. Krowchuk D.P., Stancin T., Keskinen R., et al. The psychosocial effects of acne on adolescents. Pediatr Dermatol 1991, 8(4):332-338.
8. Smithard A., Glazebrook C., Williams H.C. Acne prevalence, knowledge about acne and psychological morbidity in mid-adolescence: a community-based study. Br J Dermatol 2001, 145(2):274-279.
9. Rapp S.R., Feldman S.R., Graham G., et al. The Acne Quality of Life Index (Acne-QOLI): development and validation of a brief instrument. Am J Clin Dermatol 2006, 7(3):185-192.
10. Schipper H., Clinch J.J., Olweny C.L. Quality of life studies: definitions and conceptual issues. Quality of life and pharmacoeconomics in clinical trials 1996, 11-23. Lippincott-Raven, Philadelphia. 2nd edition. B. Spilker (Ed.).
11. Shumaker S.A., Wyman J.F., Uebersax J.S., et al. Health-related quality of life measures for women with urinary incontinence: the Incontinence Impact Questionnaire and the Urogenital Distress Inventory. Continence Program in Women (CPW) Research Group. Qual Life Res 1994, 3(5):291-306.
12. Balkrishnan R., McMichael A.J., Hu J.Y., et al. Correlates of health-related quality of life in women with severe facial blemishes. Int J Dermatol 2006, 45(2):111-115.
13. Grosshans E., Marks R., Mascaro J.M., et al. Evaluation of clinical efficacy and safety of adapalene 0.1% gel versus tretinoin 0.025% gel in the treatment of acne vulgaris, with particular reference to the onset of action and impact on quality of life. Br J Dermatol 1998, 139(Suppl 52):26-33.
14. Jones-Caballero M., Chren M.M., Soler B., et al. Quality of life in mild to moderate acne: relationship to clinical severity and factors influencing change with treatment. JEur Acad Dermatol Venereol 2007, 21(2):219-226.
15. Kellett S.C., Gawkrodger D.J. The psychological and emotional impact of acne and the effect of treatment with isotretinoin. Br J Dermatol 1999, 140(2):273-282.
16. Layton A.M., Seukeran D., Cunliffe W.J. Scarred for life?. Dermatology 1997, 195(Suppl 1):15-21. [discussion: 38-40].
17. Newton J.N., Mallon E., Klassen A., et al. The effectiveness of acne treatment: an assessment by patients of the outcome of therapy. Br J Dermatol 1997, 137(4):563-567.
18. McGrath E.J., Lovell C.R., Gillison F., et al. Aprospective trial of the effects of isotretinoin on quality of life and depressive symptoms. Br J Dermatol 2010, 163(6):1323-1329.
19. Finlay A.Y., Khan G.K. Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical use. Clin Exp Dermatol 1994, 19(3):210-216.
20. Basra M.K., Sue-Ho R., Finlay A.Y. The family dermatology life quality index: measuring the secondary impact of skin disease. Br J Dermatol 2007, 156(3):528-538.
21. Lewis-Jones M.S., Finlay A.Y. The Children's Dermatology Life Quality Index (CDLQI): initial validation and practical use. Br J Dermatol 1995, 132(6):942-949.
22. Chren M.M., Lasek R.J., Quinn L.M., et al. Skindex, a quality-of-life measure for patients with skin disease: reliability, validity, and responsiveness. JInvest Dermatol 1996, 107(5):707-713.
23. Nijsten T., Sampogna F., Abeni D. Categorization of Skindex-29 scores using mixture analysis. Dermatology 2009, 218(2):151-154.
24. Morgan M., McCreedy R., Simpson J., et al. Dermatology quality of life scales-a measure of the impact of skin diseases. Br J Dermatol 1997, 136(2):202-206.
25. Niemeier V., Kupfer J., Demmelbauer-Ebner M., et al. Coping with acne vulgaris. Evaluation of the chronic skin disorder questionnaire in patients with acne. Dermatology 1998, 196(1):108-115.
26. Beck A.T., Ward C.H., Mendelson M., et al. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571.
27. Motley R.J., Finlay A.Y. Practical use of a disability index in the routine management of acne. Clin Exp Dermatol 1992, 17(1):1-3.
28. World Health Organization International classification of impairments, disabilities, and handicaps 1980, World Health Organization, Geneva (Switzerland).
29. Motley R.J., Finlay A.Y. How much disability is caused by acne?. Clin Exp Dermatol 1989, 14(3):194-198.
30. Salek M.S., Khan G.K., Finlay A.Y. Questionnaire techniques in assessing acne handicap: reliability and validity study. Qual Life Res 1996, 5(1):131-138.
31. Finlay A.Y., Khan G.K., Luscombe D.K., et al. Validation of sickness impact profile and psoriasis disability index in psoriasis. Br J Dermatol 1990, 123(6):751-756.
32. Aghaei S., Mazharinia N., Jafari P., et al. The Persian version of the Cardiff Acne Disability Index. Reliability and validity study. Saudi Med J 2006, 27(1):80-82.
33. Dreno B., Finlay A.Y., Nocera T., et al. The Cardiff Acne Disability Index: cultural and linguistic validation in French. Dermatology 2004, 208(2):104-108.
34. Law M.P., Chuh A.A., Lee A. Validation of a Chinese version of the Cardiff Acne Disability Index. Hong Kong Med J 2009, 15(1):12-17.
35. Martin A.R., Lookingbill D.P., Botek A., et al. Health-related quality of life among patients with facial acne - assessment of a new acne-specific questionnaire. Clin Exp Dermatol 2001, 26(5):380-385.
36. Girman C.J., Hartmaier S., Thiboutot D., et al. Evaluating health-related quality of life in patients with facial acne: development of a self-administered questionnaire for clinical trials. Qual Life Res 1996, 5(5):481-490.
37. Tan J., Fung K.Y., Khan S. Condensation and validation of a 4-item index of the Acne-QoL. Qual Life Res 2006, 15(7):1203-1210.
38. Gupta M.A., Johnson A.M., Gupta A.K. The development of an Acne Quality of Life scale: reliability, validity, and relation to subjective acne severity in mild to moderate acne vulgaris. Acta Derm Venereol 1998, 78(6):451-456.
39. Carroll B.J., Feinberg M., Smouse P.E., et al. The Carroll rating scale for depression. I. Development, reliability and validation. Br J Psychiatry 1981, 138:194-200.
40. Hirschfeld R.M., Klerman G.L., Gough H.G., et al. Ameasure of interpersonal dependency. JPers Assess 1977, 41(6):610-618.
41. Hahm B.J., Min S.U., Yoon M.Y., et al. Changes of psychiatric parameters and their relationships by oral isotretinoin in acne patients. JDermatol 2009, 36(5):255-261.
42. Klassen A.F., Newton J.N., Mallon E. Measuring quality of life in people referred for specialist care of acne: comparing generic and disease-specific measures. JAm Acad Dermatol 2000, 43(2 Pt 1):229-233.
43. Kind P., Gudex C., Dolan P., et al. Practical and methodological issues in the development of the EuroQol: the York experience. Adv Med Sociol 1994, 5:219-253.
44. Ware J.E., Snow K.K., Kosinski M., et al. SF-36 health manual and interpretation guide 1993, The Health Institute, New England Medical Center, Boston.
45. Ware J.E., Sherbourne C.D. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992, 30(6):473-483.
46. Ware J.E., Kosinski M., Bayliss M.S., et al. Comparison of methods for the scoring and statistical analysis of SF-36 health profile and summary measures: summary of results from the Medical Outcomes Study. Med Care 1995, 33(Suppl 4):AS264-AS279.
47. Uhlenhake E., Yentzer B.A., Feldman S.R. Acne vulgaris and depression: a retrospective examination. JCosmet Dermatol 2010, 9(1):59-63.
48. Chren M.M., Lasek R.J., Sahay A.P., et al. Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. JCutan Med Surg 2001, 5(2):105-110.
49. Nijsten T.E., Sampogna F., Chren M.M., et al. Testing and reducing skindex-29 using Rasch analysis: Skindex-17. JInvest Dermatol 2006, 126(6):1244-1250.
50. Rapp D.A., Brenes G.A., Feldman S.R., et al. Anger and acne: implications for quality of life, patient satisfaction and clinical care. Br J Dermatol 2004, 151(1):183-189.
51. Hayashi N., Imori M., Yanagisawa M., et al. Make-up improves the quality of life of acne patients without aggravating acne eruptions during treatments. Eur J Dermatol 2005, 15(4):284-287.
52. Chren M.M., Lasek R.J., Flocke S.A., et al. Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 1997, 133(11):1433-1440.
53. Jones-Caballero M., Penas P.F., Garcia-Diez A., et al. The Spanish version of Skindex-29. Int J Dermatol 2000, 39(12):907-912.